ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Clinical trial NCT02874651 · TERMINATED
Trial details
- NCT number
- NCT02874651
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-11-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.